| 标题 |
[求助补充材料]
 Pembrolizumab or placebo with chemoradiotherapy followed by pembrolizumab or placebo for newly diagnosed, high-risk, locally advanced cervical cancer (ENGOT-cx11/GOG-3047/KEYNOTE-A18): overall survival results from a randomised, double-blind, placebo-controlled, phase 3 trial |
| 备注 |
Only Supplementary appendix, version updated 31 Oct 2024; not main article / not correction notice.
💡 该求助存在备注，如果存在信息冲突，请以备注为准
|
| 网址 | |
| DOI | |
| 其它 | Lorusso et al. The Lancet 2024;404:1321–1332. DOI 10.1016/S0140-6736(24)01808-7. KEYNOTE-A18 overall survival report. Request only the official Supplementary appendix updated 31 October 2024, as confirmed by Department of Error, Lancet 2024;404:1730, DOI 10.1016/S0140-6736(24)02371-7. Main article and correction notice are already available. Please provide the complete updated appendix with its original version/date markings; do not substitute the main article, correction notice, or the earlier PFS report appendix. For research verification. |
| 求助人 | |
| 下载 | 该求助完结已超 24 小时，文件已从服务器自动删除，无法下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)
优雅愚志
Elsevier大王
GingerF
agathahqs
渡人舟
My_magnum_opus
Rita
aaaKumaINmyMIND
Eden
AN
小牛马阿欢
Criminology34
aaa
152455
shuiyumumu
嘻嘻哈哈
mmmm
linqishi
QM
一壶古酒
皖公网安备34019202002308
